APA (7th ed.) Citation

ML, M., AE, G., AJ, D., DW, W., X, Z., BH, R., . . . Brier, M. E. (2011). Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients. Kidney International, 79(5), 546. https://doi.org/10.1038/ki.2010.468

Chicago Style (17th ed.) Citation

ML, Merchant, et al. "Oncostatin M Receptor β and Cysteine/histidine-rich 1 Are Biomarkers of the Response to Erythropoietin in Hemodialysis Patients." Kidney International 79, no. 5 (2011): 546. https://doi.org/10.1038/ki.2010.468.

MLA (9th ed.) Citation

ML, Merchant, et al. "Oncostatin M Receptor β and Cysteine/histidine-rich 1 Are Biomarkers of the Response to Erythropoietin in Hemodialysis Patients." Kidney International, vol. 79, no. 5, 2011, p. 546, https://doi.org/10.1038/ki.2010.468.